drugset / Trial / NCT06488313
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
NaSequentialOpen-labelTreatment
Summary
Evaluate the safety and pharmacodynamics of multiple doses of ARCT-810 in adolescent and adult participants with OTC deficiency.
Timeline
- Start
- 2024-11-04
- Primary completion
- 2026-06-01
- Completion
- 2026-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARCT-810 | Messenger RNA (mRNA) | — | Intravenous |